Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
File(s)nejmoa1315878.pdf (544.47 KB)
Published version
Author(s)
Type
Journal Article
Date Issued
2014-05-01
Date Acceptance
2014-05-01
Citation
New England Journal of Medicine, 2014, 370 (18), pp.1702-1711
ISSN
1533-4406
Publisher
Massachusetts Medical Society
Start Page
1702
End Page
1711
Journal / Book Title
New England Journal of Medicine
Volume
370
Issue
18
Copyright Statement
From N Engl J Med 2014; 370:1702-1711 © 2014 Massachusetts Medical Society. Reprinted with permission.
Sponsor
National Institute for Health Research
Grant Number
N/A
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
MEDICINE, GENERAL & INTERNAL
ACTIVATING-FACTOR ACETYLHYDROLASE
PHOSPHOLIPASE A(2)
ATHEROSCLEROTIC PLAQUE
CLINICAL-OUTCOMES
OXIDIZED LDL
LIPOPROTEIN
RISK
INHIBITOR
THERAPY
TRIAL
Aged
Benzaldehydes
Coronary Artery Disease
Coronary Disease
Double-Blind Method
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Myocardial Infarction
Oximes
Phospholipase A2 Inhibitors
Stroke
Treatment Failure
STABILITY Investigators
11 Medical And Health Sciences
Publication Status
Published